← Peptide Library
GLP-1 research
Tirzepatide
A dual GIP/GLP-1 receptor agonist studied for metabolic pathways.
Overview
Tirzepatide is a dual incretin peptide referenced widely in modern metabolic research.
Research background
Approved medications exist under regulated brand names; research material is for laboratory reference only.
How it works
Simultaneously engages GIP and GLP-1 receptors in laboratory models.
Common terminology
- GIP
- Glucose-dependent insulinotropic polypeptide.
- Dual agonist
- A compound acting on two receptor targets.
Storage
Refrigerate. Reconstitute with bacteriostatic water.
Mixing example
A reference mix used across the literature — plug it into the calculator to see the exact draw.
- Vial: 10 mg
- BAC water: 2 mL
- Reference dose: 2500 mcg
FAQ
How is tirzepatide different from semaglutide?
Tirzepatide targets two receptors (GIP and GLP-1) while semaglutide targets GLP-1 alone.
Educational purposes only. Nothing on MissnLnk is medical advice, diagnosis, or treatment. Research materials are not for human consumption.